1. Tuberculosis – Momentum Building to End the Epidemic David Bryden | RESULTS TB Advocacy Officer | 2015 Mandy Slutsker | ACTION Senior Associate on TB and the Global Fund | 2015

2. 9.6 million new TB cases; 480,000 were MDR-TB. Nearly 2 out of every 5 cases (37%) of TB are either undiagnosed or unreported. The majority of MDR-TB cases - 74% - are undiagnosed or unreported.

3. The Challenge Projections to 2035 compared with current trends Global Plan for 2016- 2020 Global Plan for 2016- 2020

4. Global Plan to Stop TB Funding requirement for accelerated TB response for the period 2016-2020 o Implementation (Investment packages) o Research and Development Impact of funding on the TB epidemic o Modelling of incidence, prevalence and mortality globally and by country groups

5. Goal #3 Good Health & Well-Being Ensure healthy lives and promote well-being for all at all ages. By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases. Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.

6. Global TB Caucus www.globaltbcaucus.org www.globaltbcaucus.org 612 Members of Parliament and Congress from 97 countries have signed the Barcelona Declaration.Barcelona Declaration Only 3 Members of Congress have signed on: o Rep. Eliot L. Engel o Rep. Michael McCaul o Rep. Jim McDermott November 29 and 30  2 nd Global TB Summit in Cape Town, South Africa

7. ACTION’s priorities for the year Build momentum on the WHO Global TB report, Global Plan, Global TB Summit, etc. Global Fund replenishment Getting TB into the final recommendations for the Antimicrobial Resistance (AMR) review. Expanding on TB-HIV research from 2014.

8. Voice of MDR TB patients – Nora Rodriguez, Colorado

9. Congresswoman Kay Granger with TB survivors from Texas, March 25, 2014

10. Jake Kaufman of Irvine, California -- one of 31 children infected with MDR TB in their elementary school in 2009

11. Congressional TB Champions: Rep. Engel with former Minister of Health of Lesotho

12. Congressional Action on Global TB, 2015 House: House TB Elimination Caucus – now has 38 members! Including 8 Republicans House bilateral tuberculosis letter - This bipartisan letter asked for $400 million for global tuberculosis eradication efforts and was led by Representatives Eliot Engel (D- NY), Gene Green (D-TX), Don Young (R-AK). It got a total of 49 SIGNERS! House Appropriations Committee action, 2015 – kept USAID TB funding at current level of $236 million Senate: Senate Drug Resistant Tuberculosis letter -- This letter urged the President to launch his Action Plan on Drug Resistant TB and request the needed resources. It got a total of 10 SIGNERS: Sherrod Brown (D-OH), Barbara Mikulski (D-MD), Patty Murray (D-WA), Barbara Boxer (D-CA), Sheldon Whitehouse (D-RI), Chis Coons (D- DE), Mazie Hirono (D-HI) Edward Markey (D-MA), Brian Schatz (D-HI), Robert Menendez (D-NJ) Senate Appropriations Committee action, 2015 – kept USAID TB funding at current level of $236 million

14.  USAID builds capacity for community involvement and patient-centered approaches, making it easier for patients to get diagnosed and treated.  USAID provides technical support and assists in the development of annual TB country plans -- laying the basis for success of Global Fund-backed programs.  U.S. support strengthens health systems and laboratories in affected countries. USAID helps countries adopt the latest in diagnostics, building their capacity to promptly diagnose and treat cases.  Lowering costs: USAID has helped lower medication costs for drug resistant TB by as much as 32 percent through its contribution to the Global Drug Facility.  Research that develops better MDR TB regimens that are faster and less toxic. What Does USAID TB Do?

15. There is Hope!

16. Innovations and Success The number of PLWHA receiving IPT up by 60% since 2013 Data from new surveys is showing us where TB is and who it is affecting Eight new or repurposed drugs are in development 16 countries studying feasibility of shorter MDR TB regimens 15 vaccine candidates being studied A point of care version of Xpert will be evaluated next year:

17. We need to be loud and vocal

18. NYC March participants